Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Aug 28, 2015; 21(32): 9630-9637
Published online Aug 28, 2015. doi: 10.3748/wjg.v21.i32.9630
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Flowchart of patient selection. HCC: Hepatocellular carcinoma; HR: Hepatic resection; TACE: Transarterial chemoembolization.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Comparison of overall survival across all study participants with solitary huge hepatocellular carcinoma undergoing hepatic resection or transarterial chemoembolization. HR: Hepatic resection; TACE: Transarterial chemoembolization.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Comparison of overall survival across propensity score-matched study participants with solitary huge hepatocellular carcinoma undergoing hepatic resection or transarterial chemoembolization. HR: Hepatic resection; TACE: Transarterial chemoembolization.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Disease-free survival in propensity score-matched patients with solitary huge hepatocellular carcinoma undergoing hepatic resection.